Erythropoietin-Derived Short Peptide and Its Mimics as Immuno/Inflammatory Modulators
Erythropoeitin (Epo) is a hematopoietic growth factor widely used in the treatment of anemia and has been claimed to have direct neuroprotective effects. However, long-term Epo therapy can lead to the excessive elevation of platelets and red blood cells in non-anemic individuals. A short Epo-derived peptide has recently been shown...
Inventor(s): Rui Rong Yuan, Peter Dowling, Wei Ping Li, Joseph Menonna, Yasuhiro Maeda, Bo Wang, Wei Lu, Stuart Cook
Keywords(s): Neurological disorder & neuropathic pain
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Therapeutics